Status:
COMPLETED
Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF
Lead Sponsor:
The University of Hong Kong
Conditions:
Female Infertility Due to Diminished Ovarian Reserve
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the effect of DHEA supplement on ovarian reserve markers, ovarian response to gonadotrophins and cycle outcomes in patients with normal and poor ovarian reserve. S...
Detailed Description
Consecutive patients attending subfertility clinic at the Department of Obstetrics and Gynaecology, Queen Mary Hospital who are scheduled for in-vitro fertilization (IVF) treatment will be recruited a...
Eligibility Criteria
Inclusion
- Indicated for IVF treatment according to our standard department protocol
- Age \< 40
- Regular menstrual cycles (21-35 days with \</= 4 days inter-cycle variation)
- AFC not more than 15
Exclusion
- Previous chemotherapy or pelvic irradiation
- Polycystic ovarian syndrome or polycystic ovaries
- On hormonal supplementation for any indication at the time of recruitment (e.g. estrogen, testosterone or DHEA)
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT01915186
Start Date
October 1 2010
End Date
September 1 2013
Last Update
December 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hong Kong
Hong Kong, Hong Kong